Jeffery Moran

Title: Jeffery Moran: Innovator in Cannabinoid Research

Introduction

Jeffery Moran is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of cannabinoid research, holding 2 patents that focus on the therapeutic applications of cannabinoid compounds. His work aims to address critical health issues such as alcoholism, drug abuse, and obesity.

Latest Patents

Moran's latest patents include the use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases. This patent describes novel alkylindoles that bind tightly to cannabinoid receptors, acting as neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor. These compounds are particularly useful for treating alcoholism and drug abuse, as well as obesity. Another significant patent by Moran encompasses classical cannabinoid metabolites and their uses, further expanding the potential applications of cannabinoid research.

Career Highlights

Throughout his career, Jeffery Moran has worked with esteemed institutions such as the University of Arkansas and the University of Kansas. His research has contributed to a deeper understanding of cannabinoid interactions and their potential therapeutic benefits.

Collaborations

Moran has collaborated with notable colleagues, including Anna Radominska-Pandya and Grover Miller. These partnerships have enhanced the scope and impact of his research in cannabinoid science.

Conclusion

Jeffery Moran's innovative work in cannabinoid research highlights his commitment to addressing significant health challenges. His patents reflect a dedication to developing effective treatments for alcoholism, drug abuse, and obesity.